Global DNA Diagnostics Market Size Forecast 2024 - 2033
19 Dec, 2024
What Is The Definition Of The Global DNA Diagnostics Market?
Deoxyribonucleic acid (DNA) diagnostics refers to the application of genetic testing techniques to analyze DNA, RNA, and proteins for medical, forensic, or research purposes. These tests provide insights into genetic predispositions, disease susceptibility, and ancestry. It has revolutionized medicine and genetics, providing powerful tools for understanding and managing health and disease.
DNA Diagnostics Global Market Report 2024 provides data on the global dna diagnostics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The DNA Diagnostics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.
How Is The Global DNA Diagnostics Market Size Expected To Change, And What Are The Growth Rate Projections?
The DNA diagnostics market size has grown rapidly in recent years. It will grow from $20.90 billion in 2023 to $23.10 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests. The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $34.90 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).
Which Drivers Are Accelerating Growth In The DNA Diagnostics Market?
The rising prevalence of genetic disorders is expected to drive the growth of the DNA diagnostics market going forward. Genetic disorders, caused by abnormalities in the genome, are increasingly diagnosed due to enhanced capabilities in genetic testing, environmental factors, and consanguinity, leading to better understanding and detection. DNA diagnostics precisely identify genetic disorders through genetic material analysis, enabling early diagnosis, personalized treatments, and informed family planning decisions. For example, in February 2023, the World Health Organization (WHO) reported that congenital diseases caused an estimated 240,000 infant deaths globally annually within 28 days of birth, with an additional 170,000 deaths between ages 1 month and 5 years. Therefore, the rising prevalence of genetic disorders is propelling the growth of the DNA diagnostics market.
Get Your Free Sample of the Global DNA Diagnostics Market ReportWhat Are The Core Segments Of The Global DNA Diagnostics Market?
The DNA diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry
3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications
4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC)
Which Emerging Trends Are Reshaping The DNA Diagnostics Market Size?
Leading companies in the DNA diagnostics market are developing innovative products such as liquid biopsy tests for early cancer detection. Liquid biopsies are minimally invasive tests that analyze biomarkers in the bloodstream, such as circulating tumor cells (CTCs) or cell-free DNA (cfDNA). For example, in May 2023, Laboratory Corporation, a US-based diagnostics company, launched LabCorp Plasma Focus, a new liquid biopsy test. This test identifies targeted therapies for patients with advanced solid tumors using genetic sequencing to evaluate cfDNA from tumor cells, helping oncologists tailor patient care with targeted therapy plans.
What Is The Largest Region In The DNA Diagnostics Market?
North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.